London Drugs’ Osteoporosis Screening Clinics to aid in prevention
Dubbed the ‘silent thief’, bone loss from osteoporosis occurs without symptoms – until the first fracture. According to Osteoporosis Canada, fractures from osteoporosis are more common than a heart attack, stroke or breast cancer combined, and yet over 80 per cent of fracture patients are never offered screening or treatment post fracture . Around 30,000 Canadians each year suffer from hip fractures, and many more suffer osteoporotic fractures affecting the spine, wrist, shoulder, and pelvis .
London Drugs offers Osteoporosis Screening Clinics to help patients determine their risk of developing osteoporosis, before a fracture occurs. Using the World Health Organization’s FRAX assessment tool and Sunlight Omnisense® device, Patient Care Pharmacists scan and measure the patient’s bone strength and assess their risk for falls and fractures. The consultation takes about 45-minutes.
Post-screening, patients are given an assessment of their vitamin D and calcium intake, lifestyle factors, and existing medical conditions as they relate to fracture risk. Each patient is then provided with tips on how to minimize their risks, and a personalized action plan to fit their wellness goals.
“Since osteoporosis often has no noticeable symptoms, routine screenings are crucial to help you stay informed about the changes that happen in the body during the aging process. We can develop an action plan to help improve bone health and minimize your risk,” explains Lily Liang, a Patient Care Pharmacist at London Drugs.